EMAIL DETAILS

That's terrific, I'm in Florida early next week, but if lisa can make it, I can catch up. Otherwise, I'm free later in the week.


Sent with Good (www.good.com)


-----Original Message-----
From: Lisa Barclay
Sent: Thursday, October 29, 2015 02:18 PM Eastern Standard Time
To: 'Hunter Biden'; Christopher Boies
Cc: Joan Peugh
Subject: RE: Introduction- Dennis Meheil

Thanks so much for your email. I would be happy to meet early next week.

Best,

Lisa

From: Hunter Biden [mailto:hbiden@rosemontseneca.com]
Sent: Thursday, October 29, 2015 12:46 PM
To: Christopher Boies; Lisa Barclay
Cc: Joan Peugh
Subject: Introduction- Dennis Meheil

Chris-

I got a call yesterday from Dennis Meheil, who you may know. He is currently the Chairman of U.S. Corrugated. Dennis has a relationship with a company called Northwest Biotherapeutics which produces a immunologic cancer drug that is currently undergoing testing by the FDA. They would like some help with the FDA process as they have hit some hurdles. I suggested that they hire Boies for this given Lisa’s expertise with the FDA. I have copied Lisa on this email as well.

Ideally, I would like to organize an introduction for Lisa to Dennis and Northwest’s CEO as soon as possible. They are available any time to meet. Perhaps next Monday or Tuesday would work?

Let me know how best to proceed and if you have any questions. I have copied Joan in my office who can help coordinate.

Best,
Hunter

--
R. Hunter Biden
Rosemont Seneca Partners, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-1880

________________________________
The information contained in this electronic message is confidential information intended only for the use of the named recipient(s) and may contain information that, among other protections, is the subject of attorney-client privilege, attorney work product or exempt from disclosure under applicable law. If the reader of this electronic message is not the named recipient, or the employee or agent responsible to deliver it to the named recipient, you are hereby notified that any dissemination, distribution, copying or other use of this communication is strictly prohibited and no privilege is waived. If you have received this communication in error, please immediately notify the sender by replying to this electronic message and then deleting this electronic message from your computer. [v.1]